Welcome Message
 
Our Company
 
Awards & Recognition
 
Corporate Governance
 
Management Council
Board of Directors
Reports of Insider Transactions
Committee Charters
Corporate Governance Guidelines
Additional Policies and Guidelines
Codes of Conduct
Articles of Incorporation (PDF)
Bylaws (PDF)
 
Corporate Compliance
 
Our Websites
 
Business Links

 

  » BMS.com Home » About Us » Corporate Governance » Anthony C. Hooper
SEARCH INDEX
 




Anthony C. Hooper

President, U.S. Pharmaceuticals

Anthony C. hooperTony Hooper leads the $10 billion U.S. Pharmaceuticals organization for Bristol-Myers Squibb. His team markets our medicines within the United States for serious diseases, such as cancer, HIV, hepatitis B, rheumatoid arthritis, schizophrenia, depression and cardiovascular disease.

Since being appointed to this current role in 2004, Tony has led our U.S. organization through the launch of seven new products, several serious business challenges (including significant patent expirations and external threats to existing patents) and rapid changes within the pharmaceutical industry.

Tony is inspired by the company’s mission to enhance and extend human life and proud to work for an industry that brings such great value to society. He says, “Having the opportunity to improve people’s health, quality of life and often life expectancy is why a lot of us have chosen to be in the pharmaceutical industry. We can and we do make huge differences in the lives of patients every day.”

During his tenure with Bristol-Myers Squibb, Tony has led the business in every geographic region in which Bristol-Myers Squibb has a presence. He joined Bristol-Myers Squibb in 1996 as general manager of the Australia/New Zealand business. He was then promoted to managing director of the United Kingdom and Ireland, and then to vice president and general manager for Northern Europe. In 2000 Tony became president of the company’s Asia-Pacific, Middle East and Africa region. From 2001 to 2002, he was president, Intercontinental region and, from 2002 to 2004, Tony was president, Europe, Middle East and Africa.

Prior to joining Bristol-Myers Squibb, Tony was assistant vice president of Global Marketing for Wyeth Laboratories. He also worked at Lederle International in New Jersey where he led the international marketing group. Tony assumed his first general management role as country manager for Lederle Laboratories in South Africa in 1987.

Tony was born and raised in South Africa and moved to the United States in 1989. He has a bachelor’s degree in law and a master’s in business administration from the University of South Africa. He began his career in law as a state prosecutor specializing in corporate and criminal law, and then later switched to a career in business when he began working in the pharmaceutical industry.

Tony serves on the executive boards of the National Pharmaceutical Council, the American Heart Association of Mercer County New Jersey and the Impact Young Lives Association. He also serves as an advisor to Mended Hearts, Inc.

Altogether, Tony has lived in five countries and on four continents. He resides in New Jersey with his wife.

June, 2008




[Top Page] [Search] [Index] [Contact] [Home]

Italicized product names are trademarks of Bristol-Myers Squibb Company or one of its divisions or subsidiaries. Abilify is a trademark of Otsuka Pharmaceutical Co., Ltd. Atripla is a trademark of Bristol-Myers Squibb & Gilead Sciences, LLC. Erbitux is a trademark of ImClone Systems Incorporated. EMSAM is a trademark of Somerset Pharmaceuticals, Inc. Glucophage, Glucovance and Metaglip are trademarks of Merck Santé S.A.S., an associate of Merck KGaA of Darmstadt, Germany. Avapro, Avalide and Plavix are trademarks of sanofi-aventis. Sinemet CR is a trademark of Merck & Co., Inc.

© 1999-2008 Bristol-Myers Squibb Company. Your use of the information on this site is subject to the terms of our Legal Notice and Privacy Policy.

 

SEARCH INDEX